Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - CVS Health (NYSE:CVS), Bristol-Myers Squibb (NYSE:BMY)

Core Insights - During market turbulence, investors often seek dividend-yielding stocks, which typically have high free cash flows and offer substantial dividends [1] Group 1: CVS Health Corp (NYSE:CVS) - CVS Health has a dividend yield of 3.31% [7] - Truist Securities analyst David Macdonald maintained a Buy rating and raised the price target from $92 to $95 on October 30, 2025, with an accuracy rate of 69% [7] - Morgan Stanley analyst Erin Wright maintained an Overweight rating and increased the price target from $82 to $89 on October 14, 2025, with an accuracy rate of 75% [7] - Recent news includes the appointment of David Joyner as Chair of the board of directors on November 20 [7] Group 2: Viatris Inc (NASDAQ:VTRS) - Viatris has a dividend yield of 4.49% [7] - Truist Securities analyst Srikripa Devarakonda initiated coverage with a Buy rating and a price target of $15 on October 15, 2025, with an accuracy rate of 67% [7] - Goldman Sachs analyst Matt Dellatorre initiated coverage with a Neutral rating and a price target of $10 on June 6, 2025, with an accuracy rate of 69% [7] - Recent news highlights Viatris posting upbeat earnings for the third quarter on November 6 [7] Group 3: Bristol-Myers Squibb Co (NYSE:BMY) - Bristol-Myers Squibb has a dividend yield of 5.04% [7] - Citigroup analyst Andrew Baum maintained a Neutral rating and reduced the price target from $48 to $45 on November 17, 2025, with an accuracy rate of 72% [7] - Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and cut the price target from $62 to $53 on April 28, 2025, with an accuracy rate of 71% [7] - Recent news includes the European Commission's approval for expanding the use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma on November 24 [7]